Indication
Norliqva is a calcium channel blocker for the treatment of hypertension in adults and children 6 years of age and older, to lower blood pressure. Norliqva is indicated for the treatment of coronary artery disease: chronic stable angina, vasospastic angina (Prinzmetal’s or variant angina), and angiographically documented coronary artery disease in patients without heart failure or an ejection fraction <40%.
Contraindications
NORLIQVA is contraindicated in patients with sensitivity to amlodipine.
Warnings and Precautions
NORLIQVA may cause the following conditions.
- Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis. However, acute hypotension is unlikely.
- Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of NORLIQVA, particularly in patients with severe obstructive coronary artery disease.
- Titrate slowly in patients with severe hepatic impairment.
-
Nearly60%
of US caregivers surveyed report that children regularly or always refuse medication because it has a bitter taste4,*
-
80%
of providers surveyed across multiple countries report that bitter taste impacts medication adherence4,*
*Study not performed using Norliqva or berry flavor. Norliqva has not been studied for adherence.
Dosing and administration1
- Norliqva is an oral solution
- 1 mg/mL
- Recommended adult starting dose
- 5 mg orally once daily with a maximum of 10 mg orally once daily†
- Pediatric (ages 6 and older) starting dose
- 2.5 mg to 5 mg orally once daily
May be dispensed in a tight, light-resistant container (USP), subject to compliance with the prescriber’s order/prescription and local pharmacy rules.1
Product information
†Small, fragile, or elderly patients or patients with hepatic insufficiency may be started on 2.5 mg orally once daily. Doses in excess of 5 mg daily have not been studied in pediatric patients.1
FDA-approved formulation.
No additional preparation.
Consider Norliqva as a ready-to-use oral solution alternative to compounding when clinically appropriate1,5,6
- Consistent with AAP guidance recommending use of commercially available, FDA-approved formulations when possible7,8
- Under FDA guidance, pharmacies generally should not compound products that are essentially copies of commercially available, FDA-approved products9
- Drugs that are essentially copies of a commercially available product generally may not be compounded regularly or in inordinate amounts9
Coverage opportunities with many plans†
- Covered by state Medicaid fee-for-service programs in all 50 states and the District of Columbia‡
Copay
Patients may pay as little as $0 with the EasyPay Copay Program§
Not valid for patients enrolled in Medicare, Medicaid, or other government programs. Restrictions apply, see terms.
- More than half of EasyPay redemptions had a $0 out-of-pocket cost10
- 2 out of 3 EasyPay redemptions had an out-of-pocket cost of $30 or less10
Based on EasyPay redemptions, 1/1/26 to 10/26/26. Includes commercially insured, insured-not-covered, and cash-pay claims. Individual out-of-pocket costs vary.
Click below for EasyPay Copay Card information for your patients or call 1-844-567-9503
†This piece represents coverage as of 10/20/26. Please reach out to the specific insurance carrier in question to determine coverage at the point at which you would like to access coverage. Speak directly to the applicable insurance provider to understand any individual’s specific coverage. Covered products can include considerations such as cost-sharing, prior authorization, or step therapy requirements.
‡Norliqva is covered by state Medicaid fee-for-service programs in all 50 states and the District of Columbia as of 10/20/26, according to MCO HUB. Coverage is not a guarantee of payment. Requirements vary by state and by Medicaid managed care plan and may include prior authorization, step therapy, quantity limits, or preferred drug list restrictions. Coverage is subject to change without notice. Contact the state Medicaid program or managed care plan to verify coverage for an individual patient. The EasyPay Copay Program is not valid for patients enrolled in Medicaid, or any other state or federally funded healthcare program.
§Eligible patients may pay as little as $0 per prescription through the CMP EasyPay Copay Program. Available to commercially insured, commercially uninsured and cash patients. Not valid for patients enrolled in Medicare, Medicaid, TRICARE, VA, or any other state or federally funded healthcare program, or where prohibited by law. Maximum savings of up to $150 off per 1-89-day supply and up to $450 off per 90+ day supply. Patient out-of-pocket cost will vary by insurance plan; patients with high deductibles or non-covered status may pay more than $0. Program is not health insurance, cannot be combined with other offers, and may be modified or discontinued without notice. Full terms and conditions at easypaysavings.com/terms.
Ready to meet with a representative?
Fill out this form to be contacted by a CMP representative.
Ready to order?
Order Norliqva today. Contact your wholesaler.
- 150-mL bottle
- NDC: 46287-037-01